Skip to main content

Over-the-counter medicine

Iodine povacrylex and isopropyl alcohol First approved as Duraprep

Iodine povacrylex and isopropyl alcohol (Duraprep) is an over-the-counter medicine with an FDA approval on record since 2006. No generic is listed in FDA's NDC Directory.

  • No generic listed
  • Over the counter

Check it at the source: the iodine povacrylex and isopropyl alcohol FDA label on DailyMed (effective April 23, 2026, Solventum US LLC); the NDA 21586 record on Drugs@FDA; every iodine povacrylex and isopropyl alcohol label on DailyMed.

Highlights of the record

FDA label of April 23, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

patient preoperative skin preparation: for preparation of the skin prior to surgery helps reduce bacteria that potentially can cause skin infection

Forms and strengths

  • 6.02 mg/ml / 636.4 mg/ml

Solution.

On the market

Earliest approval on file
September 29, 2006 Duraprep, Solventum; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded

What is iodine povacrylex and isopropyl alcohol used for?

From the label: indications and usage

patient preoperative skin preparation: for preparation of the skin prior to surgery helps reduce bacteria that potentially can cause skin infection

Source: FDA drug label (3M DuraPrep Surgical), Solventum US LLC, effective April 23, 2026 (SPL set 22a10a54-6a04-48b3-9ec4-b26526183daf), via openFDA; the full label on DailyMed

Is there a generic for iodine povacrylex and isopropyl alcohol (Duraprep)?

No generic iodine povacrylex and isopropyl alcohol is approved (Drugs@FDA, October 8, 2026).

  • 2006 earliest approval on file

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What next?

Check an interaction
what two or more labels say about each other